🔎 Trials Near Me

Domov › Rak endometrija › New York

Klinične študije za Rak endometrija v New York

69 študij za Rak endometrija išče udeležence na lokacijah v New York.

Mesta v New York

Uradno besedilo študije (angleško)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Northwell Health Imbert Cancer Center, Bay Shore
  • Memorial Sloan Kettering Commack, Commack
  • Northwell Health Physician Partners at Flushing, Flushing
  • in še 20
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 5. okt. 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • in še 8
Vključevanje udeležencevFaza 2
Vse starosti · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

  • START Center for Cancer Research - Long Island New York, Lake Success
  • Mount Sinai, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06840886

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START New York Long Island LLC, Lake Success
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06270706

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Phase 1 Study of the Safety and Tolerability of CTX-10726

  • START New York, Lake Success
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07419841

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Roswell Park Cancer Institute IDS, Buffalo
  • Memorial Sloan Kettering Hospital, New York
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • The Woman's Health Pavilion, Howard Beach
  • The Woman's Health Pavilion, Westbury
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05051722

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Mineola
  • Avenzo Therapeutics Recruiting Site, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05867251

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • University of Rochester, Rochester
  • State University of New York Upstate Medical University, Syracuse
  • Wilmot Cancer Institute at Webster, Webster
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 28. sep. 2026 · NCT05112601

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Ženske · Posodobljeno 25. sep. 2026 · NCT03564340

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • in še 1
Vključevanje udeležencev
Starost 18 in več · Ženske · Posodobljeno 25. sep. 2026 · NCT07270666

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, New York
  • Research Site, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06218914

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Roswell Park Cancer Institute, Buffalo
  • Mount Sinai Chelsea, New York
  • Mount Sinai Hospital, New York
  • in še 4
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT05640999

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT04590326

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Commack
Vključevanje udeležencevFaza 2
Starost 18–130 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • New York University (NYU) Langone Medical Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  • START New York-Long Island, Lake Success
  • Memorial Sloan Kettering Cancer Center (MSKCC), New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07262619

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Memorial Sloan Kettering Cancer Center Head Neck Services, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • in še 1
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 21. sep. 2026 · NCT06925724

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  • NYU Langone Hospital - Long Island, Mineola
  • NYU Langone Health, New York
  • SUNY Upstate Medical University, Syracuse
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 17. sep. 2026 · NCT06340568

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 6055), Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6004), New York
  • Memorial Sloan Kettering Cancer Center ( Site 6053), New York
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 17. sep. 2026 · NCT06952504

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Commack
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • NYU Laura and Isaac Perlmutter Cancer Center - 34th Street, New York
  • Perlmutter CC NYU Langone LI, New York
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 9. sep. 2026 · NCT07166094

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • NYU Langone Health - Long Island, Mineola
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06400472

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06515613

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, New York
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 3. sep. 2026 · NCT06989112

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07186842

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07227168

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • Icahn School of Medicine at Mount Sinai, New York
  • Montefiore Einstein Comprehensive Cancer Center, The Bronx
Vključevanje udeležencevFaza 1
Starost 15 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • Laura & Isaac Perlmutter Cancer Center, New York
  • Memorial Sloan-Kettering Cancer Center, New York
  • Mount Sinai Health System, New York
  • in še 1
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 21. avg. 2026 · NCT05548296

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06774963

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

  • Start - Ny, Long Island City
  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07470853

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START-New York Long Island, Lake Success
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06242470

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

  • Memorial Sloan Kettering Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • in še 1
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Ženske · Posodobljeno 7. avg. 2026 · NCT04291612

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
  • Clinical Research Alliance, Inc, Westbury
  • in še 1
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT06330064

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.